Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000066.xml
Rofo 2014; 186(4): 377-379
DOI: 10.1055/s-0034-1366187
DOI: 10.1055/s-0034-1366187
Promotionspreis 2013
Establishment of Functional and Molecular Ultrasound for Breast Cancer Xenograft Imaging
Etablierung von funktionellem und molekularem Ultraschall für die Bildgebung von BrustkrebsmodellenFurther Information
Publication History
16 December 2013
10 February 2014
Publication Date:
28 March 2014 (online)
Abstract
The present work was originally published in European Radiology and as a PhD thesis at the RWTH Aachen University and was conducted at the Institute for Experimental Molecular Imaging at the RWTH Aachen University.
Citation Format:
• Bzyl J. Establishment of Functional and Molecular Ultrasound for Breast Cancer Xenograft Imaging. Fortschr Röntgenstr 2014; 186: 377 – 379
Zusammenfassung
Die vorliegende Arbeit wurde in European Radiology und als Dissertation an der RWTH Aachen veröffentlicht und wurde am Institut für Experimentelle Molekulare Bildgebung der RWTH Aachen durchgeführt.
-
References
- 1 Bzyl J, Lederle W, Rix A et al. Molecular and functional ultrasound imaging in differently aggressive breast cancer xenografts using two novel ultrasound contrast agents (BR55 and BR38). Eur Radiol 2011; 21: 1988-1995
- 2 Bzyl J, Palmowski M, Rix A et al. The high angiogenic activity in very early breast cancer enables reliable imaging with VEGFR2-targeted microbubbles (BR55). Eur Radiol 2013; 23: 468-475
- 3 Bzyl J. Establishment of functional and molecular ultrasound imaging with novel, clinically translatable contrast agents for assessing the angiogenic status of two differently aggressive breast cancer xenografts. RWTH Aachen Library 2012;
- 4 Wan CF, Du J, Fang H et al. Enhancement patterns and parameters of breast cancers at contrast-enhanced US: correlation with prognostic factors. Radiology 2012; 262: 450-459
- 5 Pillai R, Marinelli ER, Fan H. A phospholipid-PEG2000 conjugate of a vascular endothelial growth factor receptor 2 (VEGFR2)-targeting heterodimer peptide for contrast-enhanced ultrasound imaging of angiogenesis. Bioconjug Chem 2010; 21: 556-562
- 6 Schneider M, Anantharam B, Arditi M et al. BR38, a new ultrasound blood pool agent. Invest Radiol 2011; 46: 486-494
- 7 Smith NR, Baker D, James NH et al. Vascular endothelial growth factor receptors VEGFR-2 and VEGFR-3 are localized primarily to the vasculature in human primary solid cancers. Clin Cancer Res 2010; 16: 3548-3561